HK Stock Market Move | HAIZHI TECH GP(02706) rose over 11% intraday; the company's agent business surged 135.6% in half a year, and the industry trajectory remains highly prosperous.
Haizhi Technology Group (02706) rose over 11% intraday, up 8.59% as of press time, at HK$46.26, with a turnover of HK$89.3013 million.
HAIZHI TECH GP(02706) rose over 11% intraday, up 8.59% as of press time, at HK$46.26, with a turnover of HK$89.3013 million.
On the news front, HAIZHI TECH GP's previously disclosed interim results report shows that the company's core growth engine, the Atlas intelligent agent business, generated revenue of RMB 115 million, a sharp year-on-year increase of 135.6%, with its revenue share jumping from about 26% in the same period last year to 38.8%, forming a "dual-wheel drive" development pattern with the traditional Atlas graph business. This means that the company's overall growth is not driven by extensive project expansion, but by structural upgrading of the high-gross-margin, high-value intelligent agent business.
It is worth mentioning that the market widely calls HAIZHI TECH GP the "Chinese version of Palantir," as the two share similarities in underlying technology and the government-enterprise service business model. Palantir's high-growth, high-profit financial reports have validated the long-term prosperity of the "graph + controllable AI" industry route. However, Qu Ke, senior vice president of the company, believes that European and American enterprises have a high degree of standardization in commercial software, with system interfaces and protocols interconnected, while Chinese enterprises mostly develop in-house and are highly customized. What they need is not a single analysis tool, but full-chain capabilities from data governance to knowledge governance. The company possesses a complete methodology and proprietary product system, giving it greater advantages in privatized deployment environments.
Related Articles

HK Stock Market Move | XTALPI (02228) rises over 5% as XtalPi Science outperforms Claude on multiple drug discovery tasks.

HK Stock Market Move | LEGENDHOLDING (03396) rises over 5% again; Citi notes that the sale of BIL is expected to narrow the NAV discount by up to about 75%.

Orient: Embodied intelligence hardware manufacturers are releasing progress intensively, and industry commercialization breakthroughs are expected to accelerate.
HK Stock Market Move | XTALPI (02228) rises over 5% as XtalPi Science outperforms Claude on multiple drug discovery tasks.

HK Stock Market Move | LEGENDHOLDING (03396) rises over 5% again; Citi notes that the sale of BIL is expected to narrow the NAV discount by up to about 75%.

Orient: Embodied intelligence hardware manufacturers are releasing progress intensively, and industry commercialization breakthroughs are expected to accelerate.

RECOMMEND





